Cat.#: ASSD-141
Description | MTT is a tetrazolium dye that is frequently employed in experiments to measure the rate of cell proliferation or growth. When MTT is introduced into living cells, it undergoes a chemical transformation facilitated by certain enzymes called NAD(P)H-dependent cellular oxidoreductases, leading to the production of formazan which is a bluish or purplish insoluble substance. |
Synonyms | Thiazolyl blue tetrazolium bromide |
Size | 500 mg, 1 g |
Applications | For used quantitation of cell viability and cell proliferation where the color intensity can be measured colormetrically (at 540 or 570 nM). |
Chemical Name | 3-(4,5-dimethyl-1,3-thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide |
Molecule Weight | 414.32 |
Molecular formula | C18H16N5SBr |
CAS Number | 298-93-1 |
PubChem identifier | 64965 |
MDL Number | MFCD00011964 |
Purity | >97% |
Solubility | Soluble in water (5 mg/ml) |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
ASSD-200 | Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) | 500 μg | inquiry |
ASSD-149 | D-Luciferin sodium salt (AC149) | 10 mg, 50 mg, 100 mg | inquiry |
ASSD-142 | Methoxy-X04 (AC142) | 10 mg, 50 mg | inquiry |
ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
ASSD-179 | 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) | 1 mg, 5 mg | inquiry |
ASSD-168 | Indo-1 AM (AC168) | 1 mg | inquiry |
ASSD-152 | Biocytin (AC152) | 10 mg, 50 mg | inquiry |
ASSD-218 | 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) | 25 mg | inquiry |
ASSD-131 | Calcein Blue (AC131) | 1 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.